Top News
Growth Rates of Small RCC Tumors Vary by Histologic Subtype
COVID-19 Pandemic Leads to Radiotherapy Interruptions in China
Risk-Stratified Therapy Reduces Late Morbidity, Mortality in Pediatric Acute Lymphoblastic Leukemia
Long-Term Zanubrutinib Treatment Effective for Majority of Patients With Waldenström Macroglobulinemia
Trial Assessing Atezolizumab in Triple-Negative Breast Cancer Misses Endpoint
Study Finds Patients With Rare Ovarian Cancer Develop Chemoresistance
Plasma DNA Assay Accurately Identifies Renal Cell Carcinoma
How Cancer Care Can Affect the Kidney
Venetoclax With Chemotherapy: Promising for Elderly Patients With AML?
Restructured Process Overcomes Barriers to Prior Authorization for Proton Therapy
Adding Radiotherapy to Chemotherapy Boosts Survival in Nasopharyngeal Carcinoma
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
Gardasil 9 for the Prevention of Some Head and Neck Cancers: Measuring the Benefit
The approval is based on evidence that the vaccine can prevent anogenital infections, with an ongoing trial looking at throat infection prevention in men likely to be critical for continued approval. -
How Patients Lose Their Own Voices: Disparities in Patient-Reported Outcome Capture in Clinical Trials
It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes. -
Children With Cancer Not Experiencing as Severe COVID-19 as Initially Feared
Studies suggest that the majority of pediatric patients with cancer and COVID-19 experience mild disease — rather than severe disease — as a result of infection with the novel virus. -
Upfront Radiation May Be a Cost-Effective Strategy in Oligorecurrent Hormone-Sensitive Prostate Cancer
Upfront metastasis-directed therapy may be a viable treatment approach in patients with oligorecurrent disease, particularly those who wish to defer systemic therapy. -
New Class of Drug Appears to Extend Survival in Patients With Triple-Refractory Multiple Myeloma
Oncopeptides will seek accelerated approval from the FDA after melflufen demonstrates a manageable safety profile. -
Study Points to a Rise in Renal Carcinomas in Children
The increase is thought to be related to environmental factors. -
Use of ICIs for Advanced Melanoma in Taiwanese Patients
It was determined that ICIs were less efficacious in Taiwanese patients with melanoma.
More Features
Researchers Reveal Racial Disparities in Access to Remdesivir for Patients With Cancer and COVID-19
Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.
A Combination of Potential Biomarkers May Help Predict Response to Immunotherapy in mRCC
Combining 2 predictors yielded better results than just using 1.
The Vital Role Genetic Testing Plays in Bladder Cancer Treatments
Recent research suggests cancer patients who have undergone genetic testing for inherited or acquired mutations were more likely to have prolonged overall survival than patients who did not,
Examining Progress and Future Directions in Follicular Lymphoma Treatment
Researchers examine how far follicular lymphoma treatment has come, what limitations still remain, and where the management of the disease is headed.
Prostate Cancer Immunotherapy Alone Is Not Enough
So far, prostate cancer immunotherapy has shown only modest benefits. To greatly improve outcomes, immunotherapy will need to be combined with other treatments, according to the authors of a recent review.
-
Loading...
-
Loading...
